Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study ; day:2 ; month:9 ; year:2020 ; pages:1-8
Clinical research in cardiology ; (2.9.2020), 1-8
- Urheber
-
Merinopoulos, Ioannis
Gunawardena, Tharusha
Wickramarachchi, Upul
Richardson, Paul
Maart, Clint
Sreekumar, Sulfi
Sawh, Chris
Wistow, Trevor
Sarev, Toomas
Ryding, Alisdair
Gilbert, Tim
Perperoglou, Aris
Vassiliou, Vassilios S.
Eccleshall, Simon C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-020-01734-6
- URN
-
urn:nbn:de:101:1-2020102322123657058971
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Merinopoulos, Ioannis
- Gunawardena, Tharusha
- Wickramarachchi, Upul
- Richardson, Paul
- Maart, Clint
- Sreekumar, Sulfi
- Sawh, Chris
- Wistow, Trevor
- Sarev, Toomas
- Ryding, Alisdair
- Gilbert, Tim
- Perperoglou, Aris
- Vassiliou, Vassilios S.
- Eccleshall, Simon C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
Paclitaxel-Coated Balloon Angioplasty in the Real World: Jack-of-all-Trades?
Investigating Balloon-Vessel Contact Pressure Patterns in Angioplasty: In Silico Insights for Drug-Coated Balloons
Systematic Scoring Balloon Lesion Preparation for Drug-Coated Balloon Angioplasty in Clinical Routine: Results of the PASSWORD Observational Study
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Anaphylaxis Following Angioplasty of the Superficial Femoral Artery with Paclitaxel-Coated Balloon: A Case Report
Association of non-insulin-dependent insulin resistance indices with lower limb artery restenosis after drug-coated balloon angioplasty
24-Month Registry Results on Drug-Coated Balloon Angioplasty Below the Knee: Strong Enough Evidence to Convince the Sceptics?
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
Paclitaxel-Coated Balloon Angioplasty in the Real World: Jack-of-all-Trades?
Investigating Balloon-Vessel Contact Pressure Patterns in Angioplasty: In Silico Insights for Drug-Coated Balloons
Systematic Scoring Balloon Lesion Preparation for Drug-Coated Balloon Angioplasty in Clinical Routine: Results of the PASSWORD Observational Study
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Anaphylaxis Following Angioplasty of the Superficial Femoral Artery with Paclitaxel-Coated Balloon: A Case Report
Association of non-insulin-dependent insulin resistance indices with lower limb artery restenosis after drug-coated balloon angioplasty
24-Month Registry Results on Drug-Coated Balloon Angioplasty Below the Knee: Strong Enough Evidence to Convince the Sceptics?
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice
Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion
Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
Paclitaxel-Coated Balloon Angioplasty in the Real World: Jack-of-all-Trades?
Investigating Balloon-Vessel Contact Pressure Patterns in Angioplasty: In Silico Insights for Drug-Coated Balloons
Systematic Scoring Balloon Lesion Preparation for Drug-Coated Balloon Angioplasty in Clinical Routine: Results of the PASSWORD Observational Study
Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study
Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Anaphylaxis Following Angioplasty of the Superficial Femoral Artery with Paclitaxel-Coated Balloon: A Case Report
Association of non-insulin-dependent insulin resistance indices with lower limb artery restenosis after drug-coated balloon angioplasty